What is another name for mometasone (furoate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Nasonex

Mometasone furoate is marketed under the brand name Nasonex 1. This is the most commonly recognized alternative name for this intranasal corticosteroid preparation.

Additional Brand Names and Formulations

Mometasone furoate is available under several other brand names depending on the formulation and geographic region:

  • Elocon - topical cream/ointment formulation (0.1%) 2, 3
  • Dezrinit - intranasal spray (registered in Russian Federation as equivalent to Nasonex) 4
  • Generic formulations - approved in multiple countries including Japan (first generic approved February 2018) 5

Key Characteristics

The medication is chemically known as 9α,21-Dichloro-11β,17-dihydroxy-16α-methylpregna-1,4-diene-3,20-dione 17-(2-furoate) with molecular formula C27H30Cl2O6 2.

Available Formulations:

  • Intranasal spray: 50 µg per spray (aqueous suspension) - marketed as Nasonex 1
  • Topical cream/ointment: 0.1% concentration - marketed as Elocon 2, 3
  • Combination products: Olopatadine/mometasone furoate (GSP301) for allergic rhinitis 6

The intranasal formulation (Nasonex) is FDA-approved for seasonal and perennial allergic rhinitis in patients ≥2 years, and for nasal polyps in adults ≥18 years 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.